Prime Medicine
PRME
PRME
122 hedge funds and large institutions have $354M invested in Prime Medicine in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 45 increasing their positions, 31 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.82% more ownership
Funds ownership: 55.58% → 57.39% (+1.8%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
24% less capital invested
Capital invested by funds: $467M → $354M (-$113M)
Holders
122
Holding in Top 10
2
Calls
$772K
Puts
$275K
Top Buyers
| 1 | +$6.96M | |
| 2 | +$4.6M | |
| 3 | +$3.27M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.26M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.95M |
Top Sellers
| 1 | -$6.66M | |
| 2 | -$5.02M | |
| 3 | -$2.54M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$2.31M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$2.13M |